Rivaroxaban CAS 366789-02-8 Maʻemaʻe >99.5% (HPLC) Factory API Kona Kiʻekiʻe

ʻO ka wehewehe pōkole:

Inoa Kemika: Rivaroxaban

CAS: 366789-02-8

Maʻemaʻe: >99.5% (HPLC)

ʻAno: Pahu keʻokeʻo a ʻaneʻane keʻokeʻo

API Kūlana Kiʻekiʻe, Hana Hana Kūʻai

E-Mail: alvin@ruifuchem.com


Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Na Waiwai Kemika:

Inoa Kimia Rivaroxaban
Nā huaʻōlelo like (S)-Rivaroxaban;(S)-5-Chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)-oxazolidin-5-yl)methyl)thiophene-2-carbox;BAY 59-7939
Helu CAS 366789-02-8
Kūlana Kūʻai Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā tona
ʻĀpana Molekala C19H18ClN3O5S
Kaumaha Molecular 435.88
Brand Kemika Ruifu

Nā kikoʻī:

'ikamu Nā kikoʻī
Ka nana aku Pauda keʻokeʻo a ʻaneʻane keʻokeʻo
ʻIkepili A Hoʻopili ka infrared absorption o Rivaroxaban i nā kūlana kuhikuhi
ʻIkepili B ʻO ka manawa paʻa o ka piko nui o ka hāpana hāpana e pili ana i ka hopena kūpono o ka ʻōnaehana, e like me ka loaʻa ʻana i ka maʻemaʻe enantiomeric.
Maʻemaʻe Enantiomeric RVX RC01: ≤0.15%
Māmā (KF) ≤0.50%
Lehu Sulphated ≤0.10%
Metala Kaumaha ≤20ppm
Acetic Acid ≤5000ppm
Nā mea pili (HPLC)
RVX RC02 ≤0.15%
RVX RC03 ≤0.15%
RVX RC04 ≤0.15%
RVX RC05 ≤0.15%
RVX RC06 ≤0.15%
RVX RC07 ≤0.15%
RVX RC08 ≤0.15%
ʻO nā mea haumia ʻē aʻe ≤0.10%
Huina paumaele <0.50%
Nā mea hoʻoheheʻe koena (GC)
Ethanol ≤5000ppm
Toluene ≤890ppm
Triethylamine ≤320ppm
Maʻemaʻe / Kaʻina Hanana >99.5% (HPLC) (ma ke kumu anhydrous)
Kūlana hoʻāʻo ʻOihana Kūlana
Hoʻohana API;Laau Antithrombotic;FXa Kaohi

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai.

Pono:

1

FAQ:

Noi:

Rivaroxaban(CAS:366789-02-8) (Xarelto, Bayer) he anticoagulant waha.ʻO ia ka mea hoʻopaneʻe Xa mea hoʻoheheʻe waha.Hōʻike ʻia ʻo Rivaroxaban no ka 'hana ʻana i ka thrombosis vein hohonu a me ka embolism pulmonary, a me ka pale ʻana i ka thrombosis hohonu hohonu a me ka embolism pulmonary i nā pākeke.No ka mālama mua ʻana i ka embolism pulmonary acute, ʻo ka rivaroxaban i ʻōlelo ʻia he 15 mg ʻelua i kēlā me kēia lā no nā lā 21 mua a ukali ʻia e 20 mg hoʻokahi i kēlā me kēia lā no ka mālama mau ʻana a me ka pale ʻana i ka thromboembolism venous hou.Non-Valvular Atrial Fibrillation (NVAF) e pale aku i ka hahau a me ka systemic embolism.ʻO ka mālama ʻana i ka VTE a me ka pale ʻana i ka VTE hou [no ka thrombosis vein hohonu (DVT) a me ka pulmonary embolism (PE)].Kāohi ʻana i nā hanana thromboembolic venous (VTE) ma ke kāʻei pani pani ʻana o ka ʻūhā a i ʻole ke kuli (THR, TKR).

E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou